Answers are grounded in this paper and cite their sources.
LR-PRP was found to have a robust expression of anti-inflammatory mediators compared with LP-PRP and may be beneficial to patients with long-term knee OA where chronic low-grade inflammation is present. Mechanistic clinical trials are needed to elucidate the key mediators in both LR-PRP and LP-PRP to assess their effect on long-term progression of knee OA.
No takes yet. Share an insight, caveat, or question.
Jayaram et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: